David Herion

2.4k total citations
20 papers, 1.8k citations indexed

About

David Herion is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, David Herion has authored 20 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 8 papers in Hepatology and 4 papers in Molecular Biology. Recurrent topics in David Herion's work include Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (5 papers). David Herion is often cited by papers focused on Hepatitis C virus research (7 papers), Liver Disease Diagnosis and Treatment (6 papers) and Hepatitis B Virus Studies (5 papers). David Herion collaborates with scholars based in United States, Malaysia and Germany. David Herion's co-authors include Jay H. Hoofnagle, David E. Kleiner, Edward Doo, Yoon Park, Marc G. Ghany, T. Jake Liang, Kittichai Promrat, Daryl Lau, Jake T. Liang and Harvey J. Alter and has published in prestigious journals such as Science, Annals of Internal Medicine and Gastroenterology.

In The Last Decade

David Herion

20 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Herion United States 15 965 927 332 177 171 20 1.8k
Bruce H. Phelps United States 21 766 0.8× 638 0.7× 160 0.5× 245 1.4× 119 0.7× 42 1.7k
Brian T. Kalish United States 24 457 0.5× 157 0.2× 380 1.1× 58 0.3× 91 0.5× 56 1.7k
Jennifer R. King United States 19 328 0.3× 127 0.1× 460 1.4× 469 2.6× 90 0.5× 61 1.9k
Kazufumi Dohmen Japan 24 1.1k 1.1× 913 1.0× 212 0.6× 106 0.6× 55 0.3× 96 2.0k
Johannes T. Brouwer Netherlands 23 1.1k 1.2× 1.2k 1.3× 123 0.4× 84 0.5× 11 0.1× 48 1.8k
Johan Iversen Denmark 18 271 0.3× 158 0.2× 237 0.7× 149 0.8× 91 0.5× 39 1.2k
Geert Robaeys Belgium 22 1.2k 1.3× 1.2k 1.3× 89 0.3× 191 1.1× 36 0.2× 94 2.1k
John F. Reinus United States 21 689 0.7× 650 0.7× 119 0.4× 69 0.4× 12 0.1× 44 1.3k
Omar Qureshi United Kingdom 16 324 0.3× 113 0.1× 326 1.0× 58 0.3× 61 0.4× 26 1.7k
Michael Scheurlen Germany 23 502 0.5× 449 0.5× 279 0.8× 77 0.4× 22 0.1× 46 1.4k

Countries citing papers authored by David Herion

Since Specialization
Citations

This map shows the geographic impact of David Herion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Herion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Herion more than expected).

Fields of papers citing papers by David Herion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Herion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Herion. The network helps show where David Herion may publish in the future.

Co-authorship network of co-authors of David Herion

This figure shows the co-authorship network connecting the top 25 collaborators of David Herion. A scholar is included among the top collaborators of David Herion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Herion. David Herion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Christopher, Pallavi Surana, Xiongce Zhao, et al.. (2017). Adult‐onset cystic fibrosis liver disease: Diagnosis and characterization of an underappreciated entity. Hepatology. 66(2). 591–601. 74 indexed citations
2.
Vawdrey, David K., Chunhua Weng, David Herion, & James J. Cimino. (2014). Enhancing electronic health records to support clinical research.. PubMed. 2014. 102–8. 5 indexed citations
3.
Goldspiel, Barry R., Willy A. Flegel, Tristan M. Sissung, et al.. (2013). Integrating pharmacogenetic information and clinical decision support into the electronic health record. Journal of the American Medical Informatics Association. 21(3). 522–528. 55 indexed citations
4.
Snell, Lawrence D., Vijay A. Ramchandani, Laura Saba, et al.. (2011). The Biometric Measurement of Alcohol Consumption. Alcoholism Clinical and Experimental Research. 36(2). 332–341. 9 indexed citations
5.
George, David T., David Herion, Monte J. Phillips, et al.. (2009). Rimonabant (SR141716) has no effect on alcohol self-administration or endocrine measures in nontreatment-seeking heavy alcohol drinkers. Psychopharmacology. 208(1). 37–44. 52 indexed citations
6.
George, David T., Jodi M. Gilman, Jacqueline Hersh, et al.. (2008). Neurokinin 1 Receptor Antagonism as a Possible Therapy for Alcoholism. Science. 319(5869). 1536–1539. 168 indexed citations
7.
Pawlosky, Robert J., Joseph R. Hibbeln, David Herion, David E. Kleiner, & Norman Salem. (2008). Compartmental analysis of plasma and liver n-3 essential fatty acids in alcohol-dependent men during withdrawal. Journal of Lipid Research. 50(1). 154–161. 10 indexed citations
8.
Nanda, Santosh Kumar, David Herion, & T. Jake Liang. (2006). Src Homology 3 Domain of Hepatitis C Virus NS5A Protein Interacts With Bin1 and Is Important for Apoptosis and Infectivity. Gastroenterology. 130(3). 794–809. 51 indexed citations
9.
Hoofnagle, Jay H., Marc G. Ghany, David E. Kleiner, et al.. (2003). Maintenance Therapy With Ribavirin in Patients With Chronic Hepatitis C Who Fail to Respond to Combination Therapy With Interferon Alfa and Ribavirin. Hepatology. 38(1). 66–74. 77 indexed citations
10.
Ghany, Marc G., David E. Kleiner, Harvey J. Alter, et al.. (2003). Progression of fibrosis in chronic hepatitis C. Gastroenterology. 124(1). 97–104. 296 indexed citations
11.
Lau, Daryl, Edward Doo, Marc G. Ghany, et al.. (2000). Long-term therapy of chronic hepatitis B with lamivudine. Hepatology. 32(4). 828–834. 288 indexed citations
12.
Baumert, Thomas F., Jujin Satoi, David Herion, et al.. (2000). Antibodies Against Hepatitis C Virus-Like Particles and Viral Clearance in Acute and Chronic Hepatitis C. Hepatology. 32(3). 610–617. 64 indexed citations
13.
Arioǧlu, Elif, Nancy G. Sebring, Kristina I. Rother, et al.. (2000). Efficacy and Safety of Troglitazone in the Treatment of Lipodystrophy Syndromes. Annals of Internal Medicine. 133(4). 263–274. 224 indexed citations
14.
Baumert, Thomas F., John Vergalla, Jujin Satoi, et al.. (1999). Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate. Gastroenterology. 117(6). 1397–1407. 104 indexed citations
15.
Herion, David, et al.. (1999). Building distributed applications with ADO. 1 indexed citations
16.
Weissbach, Lawrence, André Bernards, & David Herion. (1998). Binding of Myosin Essential Light Chain to the Cytoskeleton-Associated Protein IQGAP1. Biochemical and Biophysical Research Communications. 251(1). 269–276. 52 indexed citations
17.
Alter, Harrison, Cathy Conry‐Cantilena, Jacqueline C. Melpolder, et al.. (1997). Hepatitis C in asymptomatic blood donors. Hepatology. 26(Supplement 3). 29S–33S. 114 indexed citations
18.
Kumra, Sanjiv, et al.. (1997). Case Study: Risperidone-Induced Hepatotoxicity in Pediatric Patients. Journal of the American Academy of Child & Adolescent Psychiatry. 36(5). 701–705. 86 indexed citations
19.
Rehak, Nadja N., Stacey A. Cecco, M Ruddel, et al.. (1997). Serum ionized magnesium in chronic alcoholism: is it really decreased?. Clinical Chemistry. 43(2). 394–399. 18 indexed citations
20.
Herion, David. (1995). Vitamin D receptor (VDR) polymorphisms and bone mineral density (BMD) in primary biliary cirrhosis. Hepatology. 22(4). A289–A289. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bruce H. Phelps Breakdown of academic impact, for papers by Brian T. Kalish Breakdown of academic impact, for papers by Jennifer R. King Breakdown of academic impact, for papers by Kazufumi Dohmen Breakdown of academic impact, for papers by Johannes T. Brouwer Breakdown of academic impact, for papers by Johan Iversen Breakdown of academic impact, for papers by Geert Robaeys Breakdown of academic impact, for papers by John F. Reinus Breakdown of academic impact, for papers by Omar Qureshi Breakdown of academic impact, for papers by Michael Scheurlen
Rankless by CCL
2026